Clinical Trials · NCT01870297
A Study of LY3025876 in Participants With Diabetes
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 72
- Start date
- Jun 2013
- Locations
- 4 sites, United States
- Primary endpoint
- Number of Participants With One or More Serious Adverse Event(s) (SAEs) Considered by the Investigator to be Related to Study Drug Administration